Erneta's own Background contradicts the examiner's 'high strength' motivation for polyglactin 910
Teaching awayClaim 26Rebuts: §103 rejection of claim 26
the reinforcement strands comprise polyglactin 910
The examiner combines Erneta to make the reinforcement strands comprise polyglactin 910 on the stated rationale that doing so makes them 'commercially available, fast absorbing, and high strength.' But Erneta's own Background frames the fast-absorbing polyglactin 910 product (VICRYL RAPIDE) as a low-strength deficiency the invention seeks to overcome — it states the fast-absorbing product 'exhibits a tensile strength of about 60 percent of the standard absorbing counterpart.' A reference considered in its entirety, including passages that discredit the very property the examiner relies on, undercuts the articulated motivation to combine (MPEP § 2141.02, § 2145). The 'high strength' underpinning is therefore contradicted by the reference itself, making the stated rationale conclusory or self-defeating as applied (MPEP § 2143.01). This weakness is independent of, and in addition to, the Prommersberger base-reference problem on which claim 26 also depends.
- Erneta Background: "Commercially available braided fast absorbing suture sold by ETHICON, Inc., ... and known as VICRYL RAPIDE™ (polyglactin 910) Suture exhibits a tensile strength of about 60 percent of the standard absorbing counterpart, Coated VICRYL™ (polyglactin 910) Suture."
- OA1 Rejection 6 rationale: Erneta relied on "to make them commercially available, fast absorbing, and high strength"
- OA2 reality check: the Background "frames the fast-absorbing polyglactin 910 product as having reduced strength (about 60 percent of the standard counterpart)"
Risk The examiner may reframe the motivation around 'fast absorbing' and 'commercially available' rather than strength, or argue that ~60% strength is still adequate for a strand within a reinforced adjunct. PHE caution: characterizing polyglactin 910 as low-strength on the record could later estop counsel from arguing the claimed strands provide superior strength — weigh whether that concession is acceptable.
Likely examiner response◐ survives — moderate
The examiner can respond that the claim term is 'polyglactin 910,' a genus, and the Erneta Background describes TWO polyglactin 910 products — the fast-absorbing VICRYL RAPIDE (~60% tensile strength) AND the standard-absorbing Coated VICRYL, the higher-strength counterpart. The 60% figure characterizes only the fast-absorbing variant, so the examiner can rest the 'high strength' rationale on standard polyglactin 910 (Coated VICRYL) while relying on polyglactin 910 generally as a known, commercially available, absorbable suture material. A material described as retaining ~60% strength is not necessarily criticized, discredited, or discouraged for use in reinforcement strands (MPEP 2141.02 requires actual discouragement of the claimed path); a comparative strength statement in a Background is not a teaching away from using the genus. The examiner can also note 'commercially available' and 'fast absorbing' remain unrebutted rationales even if 'high strength' is trimmed.
How to adjust Pin down exactly which polyglactin 910 property and which product the examiner's articulated rationale relies on. If the rejection's motivation is tied to the fast-absorbing property, the ~60% strength passage is a genuine internal contradiction worth pressing (MPEP 2143.01/2145). If the examiner can retreat to standard polyglactin 910, this becomes a narrower point — consider whether the claim scope or the specific mapping lets counsel confine the examiner to the fast-absorbing variant. Develop jointly with rank 3, which supplies the evidentiary framing that the passage describes a deficiency.